Wilson Sonsini Goodrich & Rosati advised Seal Rock on the transaction. Seal Rock Therapeutics, Inc., a clinical stage company developing first-in-class and best-in-class kinase inhibitors, has...
Seal Rock Therapeutics’ Out-Licensing Agreement with GENFIT
CalciMedica’s $35 Million Merger with Graybug
Wilson Sonsini advised CalciMedica on the deal. Graybug Vision, Inc. and CalciMedica Inc. announced that they have entered into a definitive merger agreement to combine the...